Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin
- PMID: 39672169
- PMCID: PMC11732714
- DOI: 10.1016/j.ccell.2024.11.013
Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin
Abstract
Immunosuppression commonly disrupts the homeostasis of mutated normal skin, leading to widespread skin dysplasia and field cancerization. However, the immune system's role in maintaining the normal state of mutated tissues remains uncertain. Herein, we demonstrate that T cell immunity to cutaneotropic papillomaviruses promotes the homeostasis of ultraviolet radiation-damaged skin. Mouse papillomavirus (MmuPV1) colonization blocks the expansion of mutant p53 clones in the epidermis in a CD8+ T cell-dependent manner. MmuPV1 activity is increased in p53-deficient keratinocytes, leading to their specific targeting by CD8+ T cells in the skin. Sun-exposed human skin containing mutant p53 clones shows increased epidermal beta-human papillomavirus (β-HPV) activity and CD8+ T cell infiltrates compared with sun-protected skin. The expansion of mutant p53 clones in premalignant skin lesions associates with β-HPV loss. Thus, immunity to commensal HPVs contributes to the homeostasis of mutated normal skin, highlighting the role of virome-immune system interactions in preserving aging human tissues.
Keywords: CD8(+) T cell immunity; aging skin; clonal mutation; cutaneotropic papillomavirus; virome.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests D.E.F. has a financial interest in Soltego, a company developing salt inducible kinase inhibitors for topical skin-darkening treatments that might be used for a broad set of human applications. S.D. is an inventor on a filed patent for the development of T cell-directed anti-cancer vaccines against commensal viruses (PCT/US2019/063172). The interests of D.E.F. and S.D. are reviewed and managed by Massachusetts General Hospital and Mass General Brigham HealthCare in accordance with their conflict-of-interest policies.
Similar articles
-
Immunity to commensal papillomaviruses protects against skin cancer.Nature. 2019 Nov;575(7783):519-522. doi: 10.1038/s41586-019-1719-9. Epub 2019 Oct 30. Nature. 2019. PMID: 31666702 Free PMC article.
-
Beta papillomaviruses: From foe to friend in skin cancer immunity.Cancer Cell. 2025 Jan 13;43(1):6-7. doi: 10.1016/j.ccell.2024.12.005. Epub 2025 Jan 2. Cancer Cell. 2025. PMID: 39753136
-
Deficiency in Ever2 does not increase susceptibility of mice to pathogenesis by the mouse papillomavirus, MmuPV1.J Virol. 2024 Jul 23;98(7):e0017424. doi: 10.1128/jvi.00174-24. Epub 2024 Jun 13. J Virol. 2024. PMID: 38869286 Free PMC article.
-
Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.Cancer Treat Rev. 2014 Mar;40(2):205-14. doi: 10.1016/j.ctrv.2013.08.005. Epub 2013 Aug 22. Cancer Treat Rev. 2014. PMID: 24051018 Review.
-
Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis.Curr Opin Virol. 2021 Dec;51:9-15. doi: 10.1016/j.coviro.2021.09.002. Epub 2021 Sep 21. Curr Opin Virol. 2021. PMID: 34555675 Free PMC article. Review.
Cited by
-
Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor Signaling.N Engl J Med. 2025 Jul 31;393(5):469-478. doi: 10.1056/NEJMoa2502114. N Engl J Med. 2025. PMID: 40742260 Free PMC article.
-
Human Papillomavirus Vaccination and Actinic Keratosis Burden: The VAXAK Randomized Clinical Trial.JAMA Dermatol. 2025 Jun 1;161(6):605-614. doi: 10.1001/jamadermatol.2025.0531. JAMA Dermatol. 2025. PMID: 40047786 Clinical Trial.
-
Inciting commensal human papillomavirus immunity to combat cancer.Trends Cancer. 2025 Jul;11(7):616-618. doi: 10.1016/j.trecan.2025.04.006. Epub 2025 May 1. Trends Cancer. 2025. PMID: 40316467
-
Allies in the epidermis.Nat Rev Cancer. 2025 Mar;25(3):150. doi: 10.1038/s41568-025-00793-z. Nat Rev Cancer. 2025. PMID: 39885326 No abstract available.
-
Opinion: Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin.Front Microbiol. 2025 May 5;16:1576308. doi: 10.3389/fmicb.2025.1576308. eCollection 2025. Front Microbiol. 2025. PMID: 40391283 Free PMC article. No abstract available.
References
-
- Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, Wedge DC, Fullam A, Alexandrov LB, Tubio JM, et al. (2015). Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886. 10.1126/science.aaa6806. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous